Completion of Security Consolidation  
 
    Notification of cessation of securities - ME1  
 
    Notification of cessation of securities - ME1  
 
    Extension of Secured Notes  
 
    Secondary Trading Notice  
 
    Application for quotation of securities - ME1  
 
    Secondary Trading Notice  
 
    Application for quotation of securities - ME1  
 
    Results of Annual General Meeting  
 
    Response to ASX Query  
 
    Mernova Trading Update  
 
    Secondary Trading Notice  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Trading Update  
 
    Secondary Trading Notice  
 
    Application for quotation of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Consolidation/Split - ME1  
 
    Notice of Annual General Meeting/Proxy Form  
 
    Final Director's Interest Notice  
 
    Proposed issue of securities - ME1  
 
    Appointment of Tim Tian as Group CFO  
 
    Quarterly Activities/Appendix 4C Cash Flow Report  
 
    Board Change  
 
    Update - Proposed issue of securities - ME1  
 
    Secondary Trading Notice  
 
    Application for quotation of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Corporate Update  
 
    Response to ASX Aware Letter  
 
    ME1 Q1 FY24 Revenue  
 
    Proposed issue of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Health House Australia and Corporate Update  
 
    Extension of Cleansing Offer Closing Date  
 
    Proposed issue of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Mernova Trading Update  
 
    Annual Report to shareholders  
 
    Appendix 4G and Corporate Governance Statement  
 
    ME1 Q1 FY24 Revenue Update  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Notification regarding unquoted securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Disclosure Document  
 
    Response to ASX Query  
 
    FY 2023 Results  
 
    Preliminary Final Report  
 
    Secondary Trading Notice  
 
    Application for quotation of securities - ME1  
 
    Secondary Trading Notice  
 
    Application for quotation of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Capital Raising & Corporate Update  
 
    Proposed issue of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Trading Halt  
 
    Mernova Continues Strong Performance in Q1 FY24  
 
    HHI Revenue Update  
 
    Mernova Revenue Update  
 
    Appendix 2A x2 and Secondary Trading Notice  
 
    Completion of Share Consolidation  
 
    Quarterly Activities/Appendix 4C Cash Flow Report  
 
    Results of Meeting  
 
    Change of Director's Interest Notice x 2  
 
    Notification of cessation of securities - ME1  
 
    Mernova Revenue Update and Placement  
 
    Application for quotation of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Notification of cessation of securities - ME1  
 
    Consolidation/Split - ME1  
 
    Notice of General Meeting/Proxy Form  
 
    Proposed issue of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Company Secretary Appointment/Resignation  
 
    Response to Aware Query  
 
    Group Revenue Update  
 
    Change of Director's Interest Notice  
 
    Change in substantial holding  
 
    Cleansing Notice  
 
    Application for quotation of securities - ME1  
 
    Corporate Update  
 
    Proposed issue of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Extension of Prospectus Offer Closing Date  
 
    Change of Auditor  
 
    Application for quotation of securities - ME1  
 
    Change of Director's Interest Notice x 4  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Notification regarding unquoted securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Change of Director's Interest Notice  
 
    Health House Australia Revenue Update  
 
    Top 20 Holders  
 
    Distribution Schedule  
 
    Application for quotation of securities - ME1  
 
    Cancel - Proposed issue of securities - ME1  
 
    Cancel - Proposed issue of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Capital Raising Re-Price & Prospectus Offers Extension  
 
    Application for quotation of securities - ME1  
 
    Notification regarding unquoted securities - ME1  
 
    Notification regarding unquoted securities - ME1  
 
    Trading Halt  
 
    Update - Proposed issue of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Supplementary Prospectus - Bonus Options  
 
    Change of Director's Interest Notice x 4  
 
    Change in substantial holding  
 
    Ceasing to be a substantial holder  
 
    Application for quotation of securities - ME1  
 
    Becoming a substantial holder  
 
    Mernova Revenue Update  
 
    Quarterly Activities/Appendix 4C Cash Flow Report  
 
    Update - Proposed issue of securities - ME1  
 
    Prospectus - Bonus Options  
 
    Application for quotation of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Cleansing Notice  
 
    Notification regarding unquoted securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Change of Director's Interest Notice  
 
    Notification of cessation of securities - ME1  
 
    Cleansing Notice  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Capital Raising & Corporate Update  
 
    Proposed issue of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Trading Halt  
 
    Proposed issue of securities - ME1  
 
    Bonus Issue of Options and Other Corporate Updates  
 
    Mernova Q4 Revenue and New Purchase Orders Update  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Results of General Meeting  
 
    Melodiol Group Q3 Revenue Update  
 
    HHI Australian Operations Results Update  
 
    Halucenex Phase II Clinical Trial Update  
 
    Mernova Q3 Revenue Update  
 
    Mernova New Purchase Orders Update  
 
    Proposed issue of securities - ME1  
 
    Notice of General Meeting/Proxy Form  
 
    Mernova Maiden Alberta PO and Revenue Update  
 
    Proposed issue of securities - ME1  
 
    Cleansing Notice  
 
    Debt Restructure Update  
 
    Application for quotation of securities - ME1  
 
    ImpACTIVE Sponsorship Deal & Promising Regulatory Shifts  
 
    Half Year Results Commentary  
 
    Half Yearly Report and Accounts  
 
    Application for quotation of securities - ME1  
 
    Mernova Q3 Sales Update  
 
    Restricted Securities to be Released from Escrow  
 
    Cleansing Notice  
 
    Application for quotation of securities - ME1  
 
    Response to ASX Aware Query  
 
    Cleansing Notice  
 
    Application for quotation of securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Proposed issue of securities - ME1  
 
    Capital Raising and Debt to Equity Conversions  
 
    Trading Halt  
 
    LOI for Sale of Sierra Sage and Halucenex to Panacea  
 
    Cancel - Proposed issue of securities - ME1  
 
    Quarterly Activities/Appendix 4C Cash Flow Report  
 
    Mernova Makes Strong Progress on EU GMP Licence Process  
 
    Subsidiary HHI Delivers Strong Revenue & EBITDA in H1 2023  
 
    Notification of cessation of securities - ME1  
 
    Strong Start to Q3 CY2023 with $1.6m in New Revenue & POs  
 
    Record Revenue Quarter With Group Sales Up 105%  
 
    Mernova Delivers Record Half Yearly Revenues  
 
    Notification regarding unquoted securities - ME1  
 
    Application for quotation of securities - ME1  
 
    Change of Director's Interest Notice x2  
 
    Health House International Revenue Update  
 
    Appendix 3G  
 
    Appendix 2A  
 
    Appendix 2A  
 
    Appendix 3H  
 
    Appendix 2A  
 
    Change in substantial holding  
 
    Appendix 3B - Amendment  
 
    Appendix 3B  
 
    Appendix 3G  
 
    Appendix 2A  
 
    Disclosure Document  
 
    Appendix 3B  
 
    Appendix 2A  
 
    Debt Conversions and Extensions  
 
    Change of Company Name and ASX Code  
 
    Notification regarding unquoted securities - CPH  
 
    LOI to Import MDMA & Psilocybin Treatments to Australia  
 
    LOI to Import MDMA & Psilocybin Treatments to Australia  
 
    Application for quotation of securities - CPH  
 
    Notification of cessation of securities - CPH  
 
    Mernova Appoints CannDelta to Map EU GMP Export Process  
 
    Notification regarding unquoted securities - CPH  
 
    Cleansing Notice - Convertible Notes  
 
    Results of Meeting  
 
    SBC Facility - Second Purchase & Amortisation Payments  
 
    Application for quotation of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Cleansing Notice  
 
    Application for quotation of securities - CPH  
 
    Notification of cessation of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Mernova Q2 Sales Update  
 
    Proposed issue of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    Capital Raising & Debt Repayment  
 
    Trading Halt  
 
    Notification regarding unquoted securities - CPH  
 
    Response to Financial Condition Query  
 
    Application for quotation of securities - CPH  
 
    Results of Meeting  
 
    Creso Pharma Expands Asia Market Footprint  
 
    Response to ASX Price Query  
 
    Sierra Sage Herbs LLC Update  
 
    Halucenex Phase II Clinical Trial Update  
 
    Application for quotation of securities - CPH  
 
    Notice of Annual General Meeting/Proxy Form  
 
    Mernova - Eighth Province Entry & $553k in New POs  
 
    Quarterly Activities/Appendix 4C Cash Flow Report  
 
    Mernova - Q1 Cashflow Positive With Record Revenues  
 
    ASX Listing Rule 3.13.1 Notice Regarding AGM  
 
    Notice of General Meeting/Proxy Form  
 
    February Placement Update & Additional Information  
 
    Appendix 4G and Corporate Governance Statement  
 
    Annual Report to Shareholders  
 
    Notification of cessation of securities - CPH  
 
    Notification regarding unquoted securities - CPH  
 
    Resolution of Historical ASX Listing Rule Breach  
 
    Censure of Creso Pharma Limited  
 
    Cleansing Notice - Convertible Notes  
 
    Application for quotation of securities - CPH  
 
    Cancel - Proposed issue of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    $2.5M Con Note Issue, Rollover & Extinguishment of Debt  
 
    Creso Reports Strong Financial Performance in FY22  
 
    Preliminary Final Report  
 
    Secondary Trading Notice  
 
    Application for quotation of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    CPH Secures Firm Commitments to Raise $2m  
 
    Notification of cessation of securities - CPH  
 
    Trading Halt  
 
    Restricted Securities to be Released from Escrow  
 
    Creso reports strong progress across business units  
 
    Halucenex to pursue AUS entry after landmark TGA decision  
 
    Change of Director's Interest Notice x 2  
 
    Distribution Schedule  
 
    Top 20 securityholders  
 
    Appendix 2A  
 
    Application for quotation of securities - CPH  
 
    Quarterly Activities/Appendix 4C Cash Flow Report  
 
    Notification regarding unquoted securities - CPH  
 
    Notification regarding unquoted securities - CPH  
 
    Proposed issue of securities - CPH  
 
    Disclosure Document  
 
    Proposed issue of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    La Plata Debt Restructure & Abby and Finn LOI  
 
    Application for quotation of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Trading Halt  
 
    Pause in Trading  
 
    Mernova - New Province Entry & Largest Ever PO  
 
    Application for quotation of securities - CPH  
 
    Change of Director's Interest Notice x3  
 
    Notification regarding unquoted securities - CPH  
 
    Notification regarding unquoted securities - CPH  
 
    Notification of cessation of securities - CPH  
 
    Mernova wins seven new product listings in Nova Scotia  
 
    Secondary Trading Notice  
 
    Application for quotation of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    ZLD: Receipt of Creso Shares and Settlement of HHI loan  
 
    Creso raises $500k in convertible notes  
 
    Application for quotation of securities - CPH  
 
    Notification regarding unquoted securities - CPH  
 
    Results of Meeting  
 
    Top 20 Holder Report  
 
    Notice of Expiry of Listed Options  
 
    Proposed issue of securities - CPH  
 
    Secured Convertible Notes Offer Update  
 
    Notification regarding unquoted securities - CPH  
 
    Extension of March Options Offer under Prospectus  
 
    Halucenex administers first dose  
 
    Response to ASX Query  
 
    Notification regarding unquoted securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Initial Director's Interest Notice  
 
    Final Director's Interest Notice  
 
    Board Changes  
 
    Proposed issue of securities - CPH  
 
    Prospectus  
 
    Notice of General Meeting/Proxy Form  
 
    HHI Update & Product Registration Achieved in South Korea  
 
    Creso is no longer the subject of ASIC Investigation  
 
    Pause in trading  
 
    Proposed issue of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    ZLD: Partial Receipt and variation of Health House loan  
 
    Mernova Update  
 
    Replacement of Chairman  
 
    Sierra Sage Herbs LLC Expands into Canada  
 
    Secondary Trading Notice  
 
    Application for quotation of securities - CPH  
 
    Mernova Secures Cannabis 2.0 Sales License  
 
    Quarterly Activities/Appendix 4C Cash Flow Report  
 
    Proposed issue of securities - CPH  
 
    CPH Secures Commitments to Raise up to $7.6m  
 
    Trading Halt  
 
    Change of Director's Interest Notice  
 
    Notice of Breach of ASX Listing Rule 10.11  
 
    Application for quotation of securities - CPH  
 
    Final Director's Interest Notice  
 
    Initial Director's Interest Notice x2  
 
    Sierra Sage enters into agreement with accelerate360  
 
    Melodiol Global Health - Rebranding Strategy  
 
    Board Transition & Change of Company Name  
 
    Proposed issue of securities - CPH  
 
    Halucenex completes clinical trial patient recruitment  
 
    Mernova Update  
 
    Mernova Update  
 
    Notification of cessation of securities - CPH  
 
    Halucenex Update  
 
    Change of Director's Interest Notice  
 
    Becoming a substantial holder  
 
    Sierra Sage secures US$214,000 purchase order from Walmart  
 
    Half Yearly Report and Accounts  
 
    Secondary Trading Notice  
 
    Notification regarding unquoted securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Creso Pharma completes Sierra Sage Herbs LLC Acquisition  
 
    Application for quotation of securities - CPH  
 
    Halucenex Update  
 
    Secondary Trading Notice  
 
    Application for quotation of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    impACTIVE appoints New Brand Ambassador, Kolby Tullier  
 
    Results of Meeting  
 
    Proposed issue of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Mernova Update  
 
    Proposed issue of securities - CPH  
 
    Reinstatement to Official Quotation  
 
    Capital Raising & Q2 22 Quarterly Activities Report Updates  
 
    Extension to Voluntary Suspension  
 
    Quarterly Activities/Appendix 4C Cash Flow Report  
 
    HHI: Creso makes non-binding ind.proposal to acquire HHI  
 
    Execution of non-binding term sheet to acquire Health House  
 
    Suspension from Quotation  
 
    Change of Director's Interest Notice  
 
    Notification of cessation of securities - CPH  
 
    Trading Halt  
 
    SSH secures Private Label Manufacturing Agreement  
 
    Mernova Update  
 
    Halucenex Update  
 
    Proposed issue of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Creso Pharma ImpACTIVE appoints three new brand ambassadors  
 
    LOI secured with Providence Animal Health Korea Ltd  
 
    Notice of General Meeting/Proxy Form  
 
    HoA secured to launch SSH products in Singapore  
 
    Heads of Agreement secured to launch SSH products in Taiwan  
 
    Mernova Update  
 
    Application for quotation of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Notification of cessation of securities - CPH  
 
    Mernova Update  
 
    Amended Constitution  
 
    Results of Meeting  
 
    Halucenex Enters into Supply Agreement with Optimi Health  
 
    Creso Secures Heads of Agreement with Dr Pickles  
 
    Halucenex Secures Import Permit from Health Canada  
 
    Investor Presentation  
 
    Quarterly Activities/Appendix 4C Cash Flow Report  
 
    Notice of Annual General Meeting/Proxy Form  
 
    ASX Listing Rule 3.13.1 Notice Regarding AGM  
 
    Sierra Sage Increases to 110,000 Points of Sale  
 
    US ROADSHOW - COMPANY PRESENTATION  
 
    Notification regarding unquoted securities - CPH  
 
    Application for quotation of securities - CPH  
 
    US House of Representatives Passes Cannabis Act  
 
    Proposed issue of securities - CPH  
 
    Notification of cessation of securities - CPH  
 
    LOI Secured with Laboratorios Brouwer for LATAM Market  
 
    Halucenex Update  
 
    Mernova reaches significant market share milestone  
 
    Sierra Sage to unlock US product sales and manufacturing  
 
    Secondary Trading Notice  
 
    Notification of cessation of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Appendix 4G and Corporate Governance Statement  
 
    Appendix 4E and Annual Report to Shareholders  
 
    Halucenex secures Clinical Trial Authorisation  
 
    Reinstatement to Official Quotation  
 
    Proposed issue of securities - CPH  
 
    Creso Pharma secures commitments to raise $5m  
 
    Suspension From Official Quotation  
 
    Trading Halt  
 
    Mernova Operational Update  
 
    Update on Acquisition of Sierra Sage Herbs  
 
    Creso Pharma to Develop New Hemp-Based Lozenge Product  
 
    Halucenex Update  
 
    Proposed issue of securities - CPH  
 
    Investor Presentation - Sierra Sage Acquisition  
 
    Creso to enter US CBD Market through Sierra Sage Acquisition  
 
    Quarterly Activities/Appendix 4C Cash Flow Report  
 
    Application for quotation of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Halucenex Lodges Clinical Trial Authorisation  
 
    Initial Director's Interest Notice x3  
 
    Executive Director Remuneration  
 
    Proposed issue of securities - CPH  
 
    Creso Pharma Announces Three New Board Appointments  
 
    Halucenex Update  
 
    Release of Shares from Voluntary Escrow  
 
    Application for quotation of securities - CPH  
 
    Conversion of Performance Shares  
 
    Application for quotation of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Mernova on track for quarter-on-quarter revenue growth  
 
    Halucenex Awarded Dealer's License Amendment  
 
    Trading Halt  
 
    Update on Price and Volume Query Response  
 
    Trading Halt  
 
    Pause in Trading  
 
    Application for quotation of securities - CPH  
 
    Notification of cessation of securities - CPH  
 
    Response to ASX Price and Volume Query  
 
    Trading Halt  
 
    Pause in Trading  
 
    Creso Pharma Completes Integration of ImpACTIVE Assets  
 
    Creso Pharma Anticipates Increasing Q4 2021 Swiss Revenue  
 
    Dr Brian Walker Resigns as Strategic Consultant  
 
    Change of Director's Interest Notice x 3  
 
    Halucenex Receives Positive USP 61 and USP 62 Results  
 
    Notification regarding unquoted securities - CPH  
 
    Proposed issue of securities - CPH  
 
    Appointment of Hon. Dr Brian Walker as Strategic Advisor  
 
    Top 20 Holders  
 
    Distribution Schedule  
 
    Application for quotation of securities - CPH  
 
    Creso Pharma to Enter Swiss Medicinal Cannabis Market  
 
    Quarterly Activities/Appendix 4C Cash Flow Report  
 
    Application for quotation of securities - CPH  
 
    Secondary Trading Notice  
 
    Proposed issue of securities - CPH  
 
    Prospectus - Bonus Options  
 
    Creso Completes Acquisition of the Assets of ImpACTIVE  
 
    Notification regarding unquoted securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    Proposed issue of securities - CPH  
 
    Creso Pharma to Acquire ImpACTIVE Holdings Ltd Assets  
 
    Mernova Completes THC Content Testing on New Strains  
 
    Halucenex Update  
 
    Mernova Secures over A$800,000 in New Purchase Orders  
 
    Pause in Trading  
 
    Halucenex Secures Research Agreement with Acadia University  
 
    Pause in Trading  
 
    Creso Pharma Launches New E-commerce Channels  
 
    Secondary Trading Notice  
 
    Creso Secures New Purchase Orders for Human Health Products  
 
    Investor Presentation  
 
    Notification regarding unquoted securities - CPH  
 
    Proposed issue of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Creso Pharma Strengthens Management & Executive Team  
 
    Half Yearly Report and Accounts  
 
    Notification regarding unquoted securities - CPH  
 
    NASDAQ Listing & RLH Merger Update  
 
    Notification of cessation of securities - CPH  
 
    Halucenex Commissions Extraction Unit  
 
    Halucenex Awarded Dealer's License from Health Canada  
 
    Trading Halt  
 
    Pause in Trading  
 
    Mernova secures medicinal cannabis sales licence & new POs  
 
    Halucenex Continues to Make Progress ahead of Clinical Trial  
 
    Quarterly Update & Appendix 4C  
 
    Exercise of Options  
 
    Application for quotation of securities - CPH  
 
    Notification of cessation of securities - CPH  
 
    Mernova to Introduce Fourteen New Strains  
 
    Halucenex enters into a MOU with Landing Strong  
 
    Bruce Linton Confirms Position  
 
    CPH Launches cannaDOL through Multiple Distribution Channels  
 
    Change of Director's Interest Notice x 3  
 
    Creso Pharma Completes the Acquisition of Halucenex  
 
    Appendix 2A  
 
    Appendix 3G  
 
    Secondary Trading Notice  
 
    Notification of cessation of securities - CPH  
 
    Application for quotation of securities - CPH  
 
    Creso Completes Import Procedure in Uruguay for anibidiol  
 
    Change in substantial holding  
 
    Change of Director's Interest Notice  
 
    Creso Secures First Purchase Order from Red Light Holland  
 
    Halucenex Update  
 
    Reinstatement to Official Quotation  
 
    Creso's Second Consecutive Quarter of Record Revenue Growth  
 
    Suspension from Official Quotation  
 
    Trading Halt  
 
    Results of Meeting  
 
    Investor Presentation  
 
    Proposed issue of securities - CPH  
 
    Creso Pharma & Red Light Holland to Merge  
 
    Trading Halt  
 
    Creso Pharma completes US OTC dual listing  
 
    Halucenex Expands its Clinical Trials Plans  
 
    Distribution Agreement Expanded to Cover 14 Countries  
 
    Creso & Halucenex welcome Californian Senate Bill  
 
    Halucenex prepares North American market entry  
 
    Proposed issue of Securities - CPH  
 
    Update - Proposed issue of Securities - CPH  
 
    Update - Proposed issue of Securities - CPH  
 
    Update - Proposed issue of Securities - CPH  
 
    Notice of Annual General Meeting/Proxy Form  
 
    Creso Pharma signs Letter of Intent with Polvet  
 
    Creso Launches New Product  
 
    Mernova Awarded Craft Designation with OCS  
 
    Halucenex Secures Additional Pharmaceutical Grade Psilocybin  
 
    Trading Halt  
 
    Pause in Trading  
 
    Halucenex secures agreement with R&D partner Nucro-Technics  
 
    Appendix 2A  
 
    Quarterly Update & Appendix 4C  
 
    Halucenex Update  
 
    Commercial Agreement with Cannabis Queen, South Africa  
 
    ASX Listing Rule 3.13.1 Notice Regarding AGM  
 
    Halucenex Update  
 
    Mernova secures new purchase orders & launches new products  
 
    Creso appoints US executive to lead US entry strategy  
 
    Secondary Trading Notice  
 
    Appendix 2A  
 
    Creso launches three new CBD tea products  
 
    Creso continues positive progress with Halucenex  
 
    Proposed issue of Securities - CPH  
 
    Appendix 2A  
 
    Proposed issue of Securities - CPH  
 
    Creso Receives Firm Commitments to Raise $18M  
 
    Trading Halt  
 
    Creso to dual list on US OTC & Halucenex Update  
 
    Appendix 2A  
 
    New Mernova Purchase Orders & Launch of Pre-Roll Product  
 
    Final Director's Interest Notice  
 
    Halucenex Clinical Trial & Acquisition Update  
 
    Change of Director's Interest Notice  
 
    Halucenex Company Presentation  
 
    Proposed issue of Securities - CPH  
 
    Creso to Acquire Psychedelics Company, Halucenex  
 
    Appendix 4G & Corporate Governance Statement  
 
    Annual Report to shareholders  
 
    Creso Signs North American Sports Distribution Deal  
 
    Creso Signs With US Partner  
 
    Preliminary Final Report  
 
    Appendix 2A  
 
    Appendix 2A  
 
    New P.O.'s Demonstrate Strong Uptake  
 
    CPH enters Pakistan with $2.5m Distribution Deal  
 
    Appendix 2A  
 
    Creso brings cannaqix sales inhouse to improve margins  
 
    Secondary Trading Notice & Appendix 2A  
 
    New POs demonstrate patient uptake  
 
    CBD Oil legal in Australia - CPH to benefit  
 
    Quarterly Update and Appendix 4C  
 
    Change of Director's Interest Notice  
 
    Appendix 2A  
 
    Appendix 2A  
 
    Update - Proposed issue of Securities - CPH  
 
    Update - Proposed issue of Securities - CPH  
 
    Update - Proposed issue of Securities - CPH  
 
    Prospectus  
 
    Creso secures POs for record start to FY2021  
 
    Appendix 2A  
 
    CPH secures $320,000 revenue from second PO in South Africa  
 
    Appendix 2A  
 
    Becoming a substantial holder  
 
    Proposed issue of Securities - CPH  
 
    Creso readies for US cannabis legislation reform  
 
    Change of Director's Interest Notice  
 
    Creso to enter the Hash market in Canada  
 
    Appendix 2A  
 
    Results of Meeting  
 
    CPH Receives Regulatory Approval in Uruguay & Initial PO  
 
    Appendix 2A  
 
    CPH expands foot print in Canada & is now available online  
 
    Creso Welcomes TGA Decision to Reschedule CBD  
 
    Heads of Agreement to Unlock Australian Market  
 
    CPH Enters Canada's Largest Recreational Market  
 
    US House of Representatives Bill to Favour Creso in USA  
 
    Creso set to benefit from UN decision to reclassify cannabis  
 
    Creso Receives New Purchase Orders - EU  
 
    EU Ruling to Benefit Creso  
 
    Proposed issue of Securities - CPH  
 
    TGA Update  
 
    Notice of General Meeting/Proxy Form  
 
    Quarterly Update and Appendix 4C  
 
    Third Purchase Order from Nova Scotia Liquor Corporation  
 
    Ceasing to be a substantial holder  
 
    Israeli Market Update  
 
    Ceasing to be a substantial holder  
 
    Cleansing Prospectus  
 
    Secured Debt Update  
 
    Change of Director's Interest Notice x 2  
 
    Appendix 2A  
 
    Change in substantial holding  
 
    Second Purchase Order from Pharma Dynamics, South Africa  
 
    Second Retail PO from Nova Scotia Liquor Corporation  
 
    Canopy Growth founder to join Creso  
 
    Proposed issue of Securities - CPH  
 
    Proposed issue of Securities - CPH  
 
    Creso Pharma receives commitments totaling A$8.992m  
 
    Becoming a substantial holder  
 
    Ceasing to be a substantial holder  
 
    Appendix 2A  
 
    Results of Meeting  
 
    Trading Halt  
 
    Appendix 2A  
 
    Addendum to Notice of General Meeting  
 
    Mernova Receives First Retail Purchase Order From NSLC  
 
    Creso welcomes TGA reclassification of CBD  
 
    Appendix 2A  
 
    Half Yearly Report and Accounts  
 
    Proposed issue of Securities - CPH  
 
    Notice of General Meeting/Proxy Form  
 
    Company Update  
 
    Agreement with DHS Business for Entry into Iberic Markets  
 
    Appendix 2A  
 
    Quarterly Activities Report and Appendix 4C  
 
    Ceasing to be a substantial holder  
 
    Mernova Receives US$625k Order for Shipment to Israel  
 
    Redemption of Performance Shares  
 
    Ceasing to be a substantial holder  
 
    Ceasing to be a substantial holder  
 
    Appendix 2A  
 
    Becoming a substantial holder  
 
    Proposed issue of Securities - CPH  
 
    Mernova Milestone 2 Update  
 
    Issue of Unlisted Securities  
 
    Prospectus Offer Period Extension  
 
    Appendix 2A  
 
    Prospectus Offer Period Extension  
 
    Appendix 2A  
 
    Mernova Operational Update  
 
    Cleansing Prospectus  
 
    Appendix 2A  
 
    Proposed issue of Securities - CPH  
 
    Results of Meeting  
 
    Ceasing to be a substantial holder  
 
    Change in substantial holding  
 
    Israeli Cannabis Legislation Update  
 
    Update on Mernova Sales License  
 
    Change of Director's Interest Notice  
 
    Becoming a substantial holder  
 
    Successful launch of Creso's Cannamics in South Africa  
 
    Appendix 2A  
 
    Appendix 2A  
 
    Agreement for Entry into Brazilian Retail Market  
 
    Proposed issue of Securities - CPH  
 
    Cleansing Prospectus  
 
    Placement and Corporate Update